Aglinox contains repaglinide and helps stimulate the pancreas to release more insulin, thereby lowering blood sugar levels.
The active substance is repaglinide. Each tablet contains 1 mg (or 2 mg) of repaglinide.
Other ingredients: meglumine, glycerol 99.5%, povidone K30, poloxamer 188, corn starch, microcrystalline cellulose (PH 101), anhydrous calcium hydrogen phosphate, polacrilin potassium, magnesium stearate, yellow iron oxide (E172) (in 1 mg tablets only), and red iron oxide (in 2 mg tablets only).
Aglinox is an oral antidiabetic medication that contains repaglinide, which helps the pancreas produce more insulin, thereby reducing blood sugar levels.
Type II diabetes is a condition where the pancreas does not produce enough insulin to control blood sugar, or the body does not properly respond to insulin (also known as non-insulin-dependent diabetes or adult-onset diabetes).
Aglinox is used to manage Type II diabetes in combination with diet and exercise. Treatment usually begins when diet and exercise alone do not adequately control blood glucose levels. Aglinox may also be used in combination with metformin.
Your doctor will determine the appropriate dose.
The usual starting dose is 0.5 mg before meals. Swallow the tablet with a glass of water before or up to 30 minutes prior to eating.
Your doctor may increase the dose up to 4 mg taken before meals. The maximum recommended daily dose is 16 mg.
Do not take more than the dose prescribed by your doctor. Always take Aglinox exactly as directed. If unsure, consult your doctor.
Keep out of reach of children. Do not use after the expiry date stated on the blister and carton. The expiry date refers to the last day of that month.
No special storage conditions are required.
